Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Immunology of Hepatitis B
John M. Vierling
Clinics in Liver Disease (2007) Vol. 11, Iss. 4, pp. 727-759
Closed Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

Distinct plasma immune signatures in ME/CFS are present early in the course of illness
Mady Hornig, José G. Montoya, Nancy G. Klimas, et al.
Science Advances (2015) Vol. 1, Iss. 1
Open Access | Times Cited: 233
Natural History of Chronic Hepatitis B
Brian J. McMahon
Clinics in Liver Disease (2010) Vol. 14, Iss. 3, pp. 381-396
Closed Access | Times Cited: 192
KASL clinical practice guidelines: management of chronic hepatitis B

Clinical and Molecular Hepatology (2016) Vol. 22, Iss. 1, pp. 18-75
Open Access | Times Cited: 160
KASL Clinical Practice Guidelines: Management of chronic hepatitis B

Clinical and Molecular Hepatology (2012) Vol. 18, Iss. 2, pp. 109-109
Open Access | Times Cited: 144
Immune-Escape Hepatitis B Virus Mutations Associated with Viral Reactivation upon Immunosuppression
Ivana Lazarević, Ana Banko, Danijela Miljanovic, et al.
Viruses (2019) Vol. 11, Iss. 9, pp. 778-778
Open Access | Times Cited: 80
Implication of Th17 and Th1 Cells in Patients with Chronic Active Hepatitis B
Jian Ge, Kai Wang, Qinghua Meng, et al.
Journal of Clinical Immunology (2009) Vol. 30, Iss. 1, pp. 60-67
Closed Access | Times Cited: 115
Modeling the adaptive immune response in HBV infection
Noura Yousfi, Khalid Hattaf, Abdessamad Tridane
Journal of Mathematical Biology (2011) Vol. 63, Iss. 5, pp. 933-957
Closed Access | Times Cited: 103
Low Rates of Hepatitis B Virus Screening at the Onset of Chemotherapy
Jessica Hwang, Michael Fisch, Hong Zhang, et al.
Journal of Oncology Practice (2012) Vol. 8, Iss. 4, pp. e32-e39
Open Access | Times Cited: 92
Protective Immunity Against Hepatitis C: Many Shades of Gray
Mohamed S. Abdel-Hakeem, Naglaa H. Shoukry
Frontiers in Immunology (2014) Vol. 5
Open Access | Times Cited: 91
The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development
Siobhan Cashman, Brian D. Marsden, Lynn B. Dustin
Frontiers in Immunology (2014) Vol. 5
Open Access | Times Cited: 76
The role of miR‐146a in viral infection
Javid Sadri Nahand, Mohammad Reza Karimzadeh, Maria Nezamnia, et al.
IUBMB Life (2019) Vol. 72, Iss. 3, pp. 343-360
Open Access | Times Cited: 64
Involvement of Th17 and Th1 Effector Responses in Patients with Hepatitis B
Yufu Ye, Xiaojun Xie, Ji-Wei Yu, et al.
Journal of Clinical Immunology (2010) Vol. 30, Iss. 4, pp. 546-555
Closed Access | Times Cited: 82
Long‐term outcomes and predictive scores for hepatocellular carcinoma and hepatitis B surface antigen seroclearance after hepatitis B e‐antigen seroclearance
James Fung, Ka Shing Cheung, Danny Ka‐Ho Wong, et al.
Hepatology (2018) Vol. 68, Iss. 2, pp. 462-472
Closed Access | Times Cited: 58
miR146a impairs the IFN‐induced anti‐HBV immune response by downregulating STAT1 in hepatocytes
Zhaohua Hou, Qiu J. Han, Cai Zhang, et al.
Liver International (2013) Vol. 34, Iss. 1, pp. 58-68
Closed Access | Times Cited: 47
Immunosuppression in Patients with Chronic Hepatitis B
Anil B. Seetharam, Robert Perrillo, Robert G. Gish
Current Hepatology Reports (2014) Vol. 13, Iss. 3, pp. 235-244
Open Access | Times Cited: 45
The virological aspects of hepatitis B
Zina Valaydon, Stephen Locarnini
Best Practice & Research Clinical Gastroenterology (2017) Vol. 31, Iss. 3, pp. 257-264
Closed Access | Times Cited: 42
Predictors of sustained functional cure in hepatitis B envelope antigen‐negative patients achieving hepatitis B surface antigen seroclearance with interferon‐alpha–based therapy
Minghui Li, Wei Yi, Lu Zhang, et al.
Journal of Viral Hepatitis (2019) Vol. 26, Iss. S1, pp. 32-41
Closed Access | Times Cited: 40
The immunological roles in acute-on-chronic liver failure: An update
Ping Chen, Yunyun Wang, Chao Chen, et al.
Hepatobiliary & pancreatic diseases international (2019) Vol. 18, Iss. 5, pp. 403-411
Closed Access | Times Cited: 36
Three Different Functional Microdomains in the Hepatitis C Virus Hypervariable Region 1 (HVR1) Mediate Entry and Immune Evasion
Mo Guan, Wenbo Wang, Xiaoqing Liu, et al.
Journal of Biological Chemistry (2012) Vol. 287, Iss. 42, pp. 35631-35645
Open Access | Times Cited: 46
The role of tumour necrosis factor in hepatitis B infection: Jekyll and Hyde
Zina Valaydon, Marc Pellegrini, Alexander J. Thompson, et al.
Clinical & Translational Immunology (2016) Vol. 5, Iss. 12
Open Access | Times Cited: 36
Treg/Th17 imbalance and its clinical significance in patients with hepatitis B-associated liver cirrhosis
Yongting Lan, Zhen-Li Wang, Peng Tian, et al.
Diagnostic Pathology (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 31
Hepatitis B screening, prophylaxis and re-activation in the era of rituximab-based chemotherapy
Jorge Méndez-Navarro, Kathleen E. Corey, Hui Zheng, et al.
Liver International (2010) Vol. 31, Iss. 3, pp. 330-339
Open Access | Times Cited: 40
Hepatitis B virus management to prevent reactivation after chemotherapy: a review
Jessica Hwang, John M. Vierling, Andrew D. Zelenetz, et al.
Supportive Care in Cancer (2012) Vol. 20, Iss. 11, pp. 2999-3008
Open Access | Times Cited: 33
Future Therapy for Hepatitis B Virus: Role of Immunomodulators
Edward A. Pham, Ryan B. Perumpail, Benjamin Fram, et al.
Current Hepatology Reports (2016) Vol. 15, Iss. 4, pp. 237-244
Open Access | Times Cited: 27
Chronic viral hepatitis: epidemiology, molecular biology, and antiviral therapy
Stevan A. Gonzalez
Frontiers in bioscience (2010) Vol. 16, Iss. 1, pp. 225-225
Open Access | Times Cited: 32
Page 1 - Next Page

Scroll to top